CELG-RI
HealthcareBristol-Myers Squibb Company Ce · Drug Manufacturers - General · $220M
Unlock Full CELG-RI Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓Detailed 6-pillar UQS breakdown with exact scores
- ✓All 29 metrics with sector-calibrated comparisons
- ✓6 investor presets (Buffett, Munger, Lynch, Wood, Graham, Balanced)
- ✓Watchlist tracking with score alerts
- ✓AI-generated investment perspectives across 6 preset views
- ✓Score history chart with change notifications
Pro Analysis
CELG-RI — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | 68.6 | 92.4 | 48.0 | 71.9 | 27.8 | 100.0 | 0.0 |
| Jul 1, 2026 | 68.6 | 92.4 | 48.0 | 71.8 | 27.8 | 100.0 | 0.0 |
| Jun 8, 2026 | 68.6 | 92.4 | 48.0 | 71.6 | 27.8 | 100.0 | 0.0 |
| Jun 3, 2026 | 68.6 | 92.4 | 48.0 | 71.7 | 27.8 | 100.0 | +6.4 |
| May 11, 2026 | 62.2 | 90.3 | 48.0 | 42.2 | 27.8 | 100.0 | -0.4 |
| Apr 12, 2026 | 62.6 | 92.0 | 48.0 | 42.2 | 27.8 | 100.0 | -0.5 |
| Apr 11, 2026 | 63.1 | 92.0 | 50.0 | 42.2 | 27.8 | 100.0 | — |
CELG-RI — Pillar Breakdown
Quality
— 92.4/100 (25%)Bristol-Myers Squibb Company Ce demonstrates outstanding capital efficiency and profitability, placing it among the highest-quality businesses in the market.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 71.9/100 (20%)Bristol-Myers Squibb Company Ce demonstrates healthy growth trends across revenue and earnings.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 27.8/100 (15%)Bristol-Myers Squibb Company Ce presents elevated risk with concerns around leverage or financial stability.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 100.0/100 (15%)Bristol-Myers Squibb Company Ce appears attractively valued relative to its earnings, cash flows, and sector peers.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Moat
— 48/100 (25%)Bristol-Myers Squibb Company Ce possesses some competitive advantages but faces meaningful competition. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for CELG-RI.
Score Composition
Financial Data
More Stock Analysis
How is the CELG-RI UQS Score Calculated?
The UQS (Unified Quality Score) for Bristol-Myers Squibb Company Ce is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Bristol-Myers Squibb Company Ce's competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Bristol-Myers Squibb Company Ce is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.